保心汤对气虚血瘀型冠心病心绞痛患者生活质量的影响

目的：观察保心汤对气虚血瘀型冠心病心绞痛患的临床疗效。方法：采用随机对照方法，将62例患随机分为治疗组和对照组，治疗8周，观察患生活质量的变化及保心汤对心绞痛的疗效。结果：两组心绞痛、心电图疗效比较，差异无显性(P＞0．05)，在改善临床症状和生活质量方面，治疗组明显优于对照组(P＜0．05)。结论：保心汤能有效改善心肌缺血和临床症状，并能提高患的生活质量。     

应用新城疫病毒强弱毒株RT-PCR鉴别诊断技术检测多种禽类副黏病毒

应用已建立的新城疫病毒 (NDV)强、弱毒株RT PCR快速鉴别诊断技术 ,对来自广西各地疑为禽副黏病毒血清 1型 (APMV 1)感染的 14 4份不同禽类的病料进行了检测 ,并用常规方法对RT PCR检测为阳性的部分病料进行了病毒的分离和鉴定。结果 ,从鸡、鸽、鹅、鸭、鹌鹑、珍珠鸡、孔雀、鸵鸟和画眉鸟 9种禽的病料样品中检测到APMV 1,阳性检出率为 6 4.5 8% (93/ 14 4 ) ;从 7种禽病料中分离到 2 9株APMV 1地方野毒株。部分分离株用NDV强、弱毒株快速鉴别技术鉴定属中、强毒株。     

我国警察健康权益的现状分析与对策

目前我国警察身体健康和心理健康方面存在的问题不容忽视,保护警察合法权益,需建立健全警察权益保障法律制度,建立专门的警察权益监督保障机构,建立非警务活动审批监督机构,设立警察权益保护基金等。     

多重RT-PCR快速检测鉴别新城疫病毒强毒株和弱毒疫苗株方法的建立

根据新城疫病毒(NDV)基因结构的特点及强、弱毒株融合基因裂解位点的序列差异设计了4条引物,建立了一种可以快速鉴别NDV强毒株和弱毒疫苗株的多重PCR方法。检测结果显示,强毒株可以扩增出442 bp的特异性片段和671 bp的通用片段,弱毒疫苗株可以扩增出252bp的特异性片段和671 bp的通用片段。该方法只需进行一次RT-PCR,整个过程可在数小时内完成。经敏感性测定,该方法最低能检测到100 pg的NDV RNA。     

新疆部分规模化猪场繁殖障碍类疫病的调查与防制

从新疆 13个地区的 2 5个规模化猪场采集猪流产胎儿、死胎和血清等病料 330 0余份 ,进行血清学和病原学检测 ,查明猪瘟和伪狂犬病、猪生殖和呼吸综合征是造成规模化猪场猪繁殖障碍的主要疫病 ;并通过试验研究 ,提出了防制方案 ,在生产中推广应用取得了较好的效果     

损伤伴心血管系统疾病死亡42例法医病理学研究

目的探讨心血管系统疾病伴外伤死亡案例法医病理学特点,并从伤病的角度揭示两者之间的联系。方法42例心血管系统疾病伴损伤死亡案例均接受系统病理学解剖和组织学观察,且死因明确。结果42例中40岁以上者占到64.28%,男性较女性死者多。擦伤和挫伤在损伤中比例最大共占到80.95%,冠心病和高血压病死亡者各占45.24%、16.67%。损伤和疾病共存死亡案例共20例。结论在死因分析中年龄、性别、损伤类型、疾病分布有其规律性,死者中年龄偏老年化,损伤多为钝器、摔跌所致擦伤、挫伤。疾病中冠心病、高血压为最多。损伤和疾病对死因共同起作用的案例主。     

过敏性和冠心病猝死者心肌组织中肥大细胞类胰蛋白酶、脑利钠肽的表达

目的探讨肥大细胞类胰蛋白酶、脑利钠肽(brain natriuretic peptide,BNP)在过敏性猝死和冠心病猝死鉴别诊断中的意义。方法选取山西医科大学法医病理学教研室2010—2015年尸检案例心肌标本共30例,分为颅脑损伤致死组、过敏性猝死组、冠心病猝死组,每组各10例。采用免疫荧光染色和Western印迹法分析各组心肌组织肥大细胞类胰蛋白酶和BNP的表达。结果过敏性猝死组、冠心病猝死组心肌组织内肥大细胞类胰蛋白酶免疫荧光染色均出现阳性染色;三组间两两比较,表达差异均具有统计学意义(P0.05)。冠心病猝死组心肌组织内BNP的表达量高于过敏性猝死组、颅脑损伤致死组(P0.05),过敏性猝死组与颅脑损伤致死组之间差异无统计学意义(P0.05)。结论联合检测心肌组织内肥大细胞类胰蛋白酶、BNP有望为过敏性猝死和冠心病猝死的法医学鉴别诊断提供帮助。     

A Case of Sudden Infant Death Due to Incomplete Kawasaki Disease

Although Kawasaki disease (KD) is a self‐limiting disease, it may cause sudden cardiac death. Diagnosis of KD is principally based on clinical signs; however, some infant cases do not meet the criteria. Such cases are identified as incomplete KD. The sudden death risk in incomplete KD cases is similar to conventional KD. In our 5‐month‐old case, he had been admitted to a hospital for a fever and suppuration at the site of Bacille de Calmette et Guerin (BCG) vaccination. However, after discharge from the hospital, his C‐reactive protein (CRP) levels declined, he got indisposed and died suddenly. A medico‐legal autopsy revealed myocarditis, coronaritis, platelet‐aggregated emboli in coronary arteries, and myocardial degeneration, suggesting that the fatal myocardial infarction was due to thrombus emboli in the coronary arteries. Forensic pathologists therefore should pay attention to the cardiac pathology originated from incomplete KD as a potential cause in cases of sudden infant death.     

Commode Cardia—Death by Valsalva Maneuver: A Case Series

The Valsalva maneuver is used in clinical medicine for the diagnosis and/or treatment of various cardiovascular conditions. It can also be used in activities of daily living, such as defecation. Due to the cardiovascular effects produced during the Valsalva maneuver, it may be contraindicated in certain medical conditions and could be a trigger of sudden cardiac death. The incidence and prevalence of death following Valsalva maneuver in the presence of underlying cardiovascular disease, or “commode cardia,” has not been examined. In 2012, the Wayne County Medical Examiner's Office (Detroit, MI) investigated 21 deaths that occurred on the toilet, fourteen of which were due to cardiovascular disease. In another 31 deaths in the bathroom due to cardiovascular disease, the possibility that the decedent defecated immediately prior to death could not be excluded. Hence, the incidence of commode cardia in this population ranges from 2.3 to 7.4% of all cardiovascular‐related deaths.     

When benefitting a patient increases the risk for harm for third persons — The case of treating pedophilic Parkinsonian patients with deep brain stimulation

This paper investigates the question whether it is ethically justified to treat Parkinsonian patients with known or suspected pedophilia with deep brain stimulation — given increasing evidence that this treatment might cause impulse control disorders, disinhibition, and hypersexuality. This specific question is not as exotic as it looks at a first glance. First, the same issue is raised for all other types of sexual orientation or behavior which imply a high risk for harming other persons, e.g. sexual sadism. Second, there are also several (psychotropic) drugs as well as legal and illegal leisure drugs which bear severe risks for other persons. We show that Beauchamp and Childress' biomedical ethics fails to derive a veto against medical interventions which produce risks for third persons by making the patients dangerous to others. Therefore, our case discussion reveals a blind spot of the ethics of principles. Although the first intuition might be to forbid the application of deep brain stimulation to pedophilic patients, we argue against such a simple way out, since in some patients the reduction of dopaminergic drugs allowed by deep brain stimulation of the nucleus subthalamicus improves impulsive control disorders, including hypersexuality. Therefore, we propose a strategy consisting of three steps: (1) risk assessment, (2) shared decision-making, and (3) risk management and safeguards.